Hypnotics: An update

Current Neurology and Neuroscience Reports

Volumn 3, Issue 2, 2003, Pages 181-184

  Roehrs, Timothy ^a   Roth, Thomas ^a  

^a HENRY FORD HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BENZODIAZEPINE RECEPTOR STIMULATING AGENT; HYPNOTIC AGENT; TRIAZOLAM; ZALEPLON; ZOLPIDEM; 4 AMINOBUTYRIC ACID A RECEPTOR; HYPNOTIC SEDATIVE AGENT;

AMNESIA; COGNITIVE DEFECT; DROWSINESS; DRUG DEPENDENCE; DRUG EFFICACY; DRUG HALF LIFE; DRUG RECEPTOR BINDING; DRUG SAFETY; DRUG TOLERABILITY; HANGOVER; HUMAN; INSOMNIA; PSYCHOMOTOR DISORDER; REBOUND; RECEPTOR DOWN REGULATION; REM SLEEP; RETROSPECTIVE STUDY; REVIEW; SEDATION; SIDE EFFECT; SLEEP PATTERN; SLEEP TIME; SOMNOLENCE; WITHDRAWAL SYNDROME; ADDICTION; CHEMICALLY INDUCED DISORDER; CHRONIC DISEASE; DRUG POTENTIATION; SLEEP DISORDER;

AMNESIA; CHRONIC DISEASE; HUMANS; HYPNOTICS AND SEDATIVES; RECEPTORS, GABA-A; SLEEP DISORDERS; SLEEP INITIATION AND MAINTENANCE DISORDERS; SUBSTANCE-RELATED DISORDERS;

EID: 0038182594     PISSN: 15284042     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11910-003-0074-1     Document Type: Review

References (30)

1. National Institute of Mental Health, Consensus Development Conference: Drugs and insomnia: the use of medication to promote sleep. JAMA 1984, 251:2410-2414.
2. Roth T, Roehrs TA, Vogel GW, Dement WC: Evaluation of hypnotic medications. In Clinical Evaluation of Psychotropic Drugs, Principles and Guidelines. Edited by Prien RF, Robinson DS. New York: Raven Press; 1995:579-592.
3. Scharf MB, Roth T, Vogel GW, Walsh JK: A multicenter, placebo-controlled study evaluating zolpidem in the treatment of chronic insomnia. J Clin Psychiatry 1994, 55:192-199.
4. Karacon I, Orr W, Roth T, et al.: Dose-related effects of phenobabitone on human sleep-waking patterns. Br J Clin Pharm 1981, 12:303-313.
5. Vogel GW, Buffenstein A, Minter K: Drug effects on REM sleep and on endogenous depression. Neurosci Biobehav Rev 1990, 14:49-63.
6. Feinberg I, Fein G, Walker JM, et al.: Flurazepam effects on sleep EEG: visual, computer and cycle analysis. Arch Gen Psychiatry 1979, 36:95-102.
7. Feinberg I, Maloney T, Campbell IG: Effects of hypnotics on the sleep EEG of healthy young adults: new data and psychopharmacologic implications. J Psychiatry Res 2000, 34:423-438.
8. Cluydts R, Peeters K, Bouyalsky I, Lavoisy J: Comparison of continuous versus intermittent administration of zolpidem in chronic insomniacs: a double-blind randomized pilot study. J Int Med Res 1998, 26:13-24.
9. Roehrs T, Pedrosi B, Rosenthal L, Roth T: Hypnotic self-administration: forced choice versus single choice. Psychopharmacology 1997, 133:121-126.
10. Roehrs T, Bonahoom A, Pedrosi B, et al.: Treatment regimen and hypnotic self-administration. Psychopharmacology 2001, 155:11-17.
11. Walsh JK, Roth T, Randazzo A, et al.: Eight weeks of non-nightly use of zolpidem for primary insomnia. Sleep 2000, 23:1087-1096.
12. Dooly M, Plosker GL: Zaleplon: a review of its use in the treatment of insomnia. Drugs 2000, 60:413-445.
13. Mendelson WB: Hypnotics: basic mechanisms and pharmacology. In Principles and Practice of Sleep Medicine. Edited by Kyger MH, Roth T, Dement WC. Philadelphia: WB Saunders; 2000:407-413.
14. Roth T, Roehrs T: Issues in the use of benzodiazepine therapy. J Clin Psychiatry 1992, 53:S14-S18.
15. Danjou P, Paty I, Fruncillo R: A comparison of the residual effects of zaleplon and zolpidem following administration 5 to 2 hrs before awakening. Br J Clin Pharmacol 1999, 48:367-374.
16. Roth T, Roehrs TA, Stepanski EJ, Zorick F: Hypnotics and behavior. Am J Med 1990, 88:43S-46S.
17. Roehrs T, Zorick F, Sicklesteel J, Roth T: Effects of hypnotics on memory. J Clin Psycholpharmacol 1983, 3:310-313.
18. Roehrs T, Merlotti L, Zorick F, Roth T: Sedative, memory, and performance effects of hypnotics. Psychopharmacology 1994, 116:130-134.
19. Holm KJ, Goa KL: Zolpidem: a update of its pharmacology, therapeutic efficacy and tolerability in the treatment of insomnia. Drugs 2000, 59:865-889.
20. Roehrs T, Vogel G, Roth T: Rebound insomnia: its determinants and significance. Am J Med 1990, 88:39S-42S.
21. Roehrs T, Merlotti L, Zorick F, Roth T: Rebound insomnia and hypnotic self administration. Psychopharmacology 1992, 107:480-484.
22. Balter MB, Uhlenhuth EH: The beneficial and adverse effects of hypnotics. J Clin Psychiatry 1991, 52:S16-S23.
23. Walsh JK, Schweitzer PK: Ten year trends in the pharmacological treatment of insomnia. Sleep 1999, 22:371-375.
24. Johnson EO, Roehrs T, Roth T, Breslau N: Epidemiology of alcohol and medication as aids to sleep in early adulthood. Sleep 1998, 21:178-186.
25. Mellinger GD, Balter MB, Uhlenhuth EH: Insomnia and its treatment: prevalence and correlates. Arch Gen Psychiatry 1985, 42:225-232.
26. Woods JH, Katz JL, Winger G: Benzodiazepines: use, abuse, and consequences. Pharmacol Rev 1992, 44:151-347.
27. Woods JH, Winger G: Current benzodiazepine issues. Psychopharmacology 1995, 11:107-115.
28. Roehrs T, Bonahoom A, Pedrosi B, et al.: Disturbed sleep predicts hypnotic self-administration. Sleep Med 2002, 3:61-66.
29. Roehrs T, Pedrosi B, Rosenthal L, Roth T: Hypnotic self administration and dose escalation. Psychopharmacology 1996, 127:150-154.
30. Roehrs T, Bonahoom A, Pechosi B, et al.: Nighttime versus daytime hypnotic self-administration. Psychopharmacology 2002, 161:137-142.